FTSE MIB
34.166,57 -129,74 (-0,38%) Dow Jones
38.386,09 +146,43 (+0,38%) Nasdaq
15.983,08 +55,18 (+0,35%) Nikkei 225
38.405,66 +470,90 (+1,24%) Petrolio
82,84 +0,21 (+0,25%) Bitcoin EUR
58.726,11 -631,68 (-1,06%)
Affiliated Managers Group, Inc. (AMG)
Dopo ore:
| Chiusura precedente | 160,20 |
| Aperto | 160,41 |
| Denaro | 63,64 x 3100 |
| Lettera | 0,00 x 800 |
| Min-Max giorno | 158,24 - 161,73 |
| Intervallo di 52 settimane | 120,22 - 169,65 |
| Volume | |
| Media Volume | 239.609 |
| Capitalizzazione | 5,158B |
| Beta (5 anni mensile) | 1,32 |
| Rapporto PE (ttm) | 9,12 |
| EPS (ttm) | 17,42 |
| Prossima data utili | 06 mag 2024 |
| Rendimento e dividendo (futuro) | 0,04 (0,03%) |
| Data ex dividendo | 14 feb 2024 |
| Stima target 1A | 197,00 |
GlobeNewswireAMG Appoints Loren M. Starr to its Board of Directors
WEST PALM BEACH, Fla., Sept. 25, 2023 (GLOBE NEWSWIRE) -- AMG, a leading partner to independent investment management firms globally, today announced the appointment of Loren M. Starr to its Board of Directors, effective immediately. Mr. Starr retired from Invesco Ltd. in March 2021, having served as Chief Financial Officer of the company for 15 years, from 2005 to 2020, after which he held an executive advisory role as Invesco’s Vice Chair until his retirement. Prior to joining Invesco in 2005,
GlobeNewswireAMG Completes Investment in Forbion
WEST PALM BEACH, Fla., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Affiliated Managers Group, Inc. (NYSE: AMG), a leading partner to independent investment management firms globally, today announced the completion of its investment in Forbion Group Holding B.V. (“Forbion”). Forbion is a leading pan-European venture capital and growth equity firm focused on investing in high-quality life sciences companies across all stages of their development. With approximately €3 billion in assets under management, For
- GlobeNewswire
AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2023
Company reports EPS of $3.25, Economic EPS of $4.45 in the second quarter of 2023 Announced partnership with Forbion, a leading European life sciences venture capital and growth equity firmNet Income (controlling interest) of $125 million, Economic Net Income of $167 millionEconomic Earnings per share of $4.45 increased 10% year-over-yearCompleted $225 million accelerated share repurchase program and repurchased an additional $44 million of common stockGross proceeds of approximately $294 millio
